UCB reported EUR42.5B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 37.06B 5.98B Mar/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
argenx SE USD 57.63B 13.25B Jun/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Bayer EUR 49.51B 10.82B Aug/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Orion EUR 10.15B 316M Jun/2026
Recordati EUR 10.65B 209.88M Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025
Unibail Rodamco EUR 14.55B 1.26B Aug/2026